Dec 11, 2024 · NEW HAVEN, Conn.– (BUSINESS WIRE)–Veradermics, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for …
Veradermics aims to change this. We’re a new style of pharmaceutical company: driven by purpose, powered by science, and committed to bold therapeutic progress. Our differentiated pipeline is …
Oct 16, 2025 · Veradermics’ lead program, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for the treatment of pattern hair loss — the largest aesthetics condition …
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Feb 9, 2026 · Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Veradermics is advancing a focused pipeline of product candidates designed to address high-value dermatologic conditions with limited proven solutions, combining proven mechanisms with innovative …
Feb 9, 2026 · Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Dec 11, 2025 · Veradermics’ lead program, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for the treatment of pattern hair loss — the largest aesthetics condition …
Feb 4, 2026 · Veradermics is on a mission to make long-ignored dermatology and aesthetics conditions simple — replacing false hope, confusion, and questionable results with solutions that people and …
Dec 11, 2024 · NEW HAVEN, Conn.– (BUSINESS WIRE)–Veradermics, a late clinical-stage aesthetics and dermatology-focused biopharmaceutical company developing first-in-class therapeutics for …
Veradermics aims to change this. We’re a new style of pharmaceutical company: driven by purpose, powered by science, and committed to bold therapeutic progress. Our differentiated pipeline is …
Oct 16, 2025 · Veradermics’ lead program, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for the treatment of pattern hair loss — the largest aesthetics condition …
Here’s a link to a business post made a couple of days ago. https://www.bloomberg.com/news/articles/2026-02-04/hair-loss-firm-veradermics-jumps-124-after-256-million-ipo As of now it’s market c...
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Feb 9, 2026 · Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
Veradermics is advancing a focused pipeline of product candidates designed to address high-value dermatologic conditions with limited proven solutions, combining proven mechanisms with innovative …
Feb 9, 2026 · Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on turning everyday dermatology and aesthetics problems into clear, proven care.
